134 related articles for article (PubMed ID: 7970432)
1. 166Ho-microsphere liver radiotherapy: a preclinical SPECT dosimetry study in the pig.
Turner JH; Claringbold PG; Klemp PF; Cameron PJ; Martindale AA; Glancy RJ; Norman PE; Hetherington EL; Najdovski L; Lambrecht RM
Nucl Med Commun; 1994 Jul; 15(7):545-53. PubMed ID: 7970432
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging-based radiation-absorbed dose estimation of 166Ho microspheres in liver radioembolization.
Seevinck PR; van de Maat GH; de Wit TC; Vente MA; Nijsen JF; Bakker CJ
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e437-44. PubMed ID: 22633554
[TBL] [Abstract][Full Text] [Related]
3. Holmium-166 radioembolization for the treatment of patients with liver metastases: design of the phase I HEPAR trial.
Smits ML; Nijsen JF; van den Bosch MA; Lam MG; Vente MA; Huijbregts JE; van het Schip AD; Elschot M; Bult W; de Jong HW; Meulenhoff PC; Zonnenberg BA
J Exp Clin Cancer Res; 2010 Jun; 29(1):70. PubMed ID: 20550679
[TBL] [Abstract][Full Text] [Related]
4. In vivo dosimetry based on SPECT and MR imaging of 166Ho-microspheres for treatment of liver malignancies.
Smits ML; Elschot M; van den Bosch MA; van de Maat GH; van het Schip AD; Zonnenberg BA; Seevinck PR; Verkooijen HM; Bakker CJ; de Jong HW; Lam MG; Nijsen JF
J Nucl Med; 2013 Dec; 54(12):2093-100. PubMed ID: 24136931
[TBL] [Abstract][Full Text] [Related]
5. Safety of a Scout Dose Preceding Hepatic Radioembolization with 166Ho Microspheres.
Prince JF; van Rooij R; Bol GH; de Jong HW; van den Bosch MA; Lam MG
J Nucl Med; 2015 Jun; 56(6):817-23. PubMed ID: 25931477
[TBL] [Abstract][Full Text] [Related]
6. Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study.
Smits ML; Nijsen JF; van den Bosch MA; Lam MG; Vente MA; Mali WP; van Het Schip AD; Zonnenberg BA
Lancet Oncol; 2012 Oct; 13(10):1025-34. PubMed ID: 22920685
[TBL] [Abstract][Full Text] [Related]
7. 166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapy.
Breitz HB; Wendt RE; Stabin MS; Shen S; Erwin WD; Rajendran JG; Eary JF; Durack L; Delpassand E; Martin W; Meredith RF
J Nucl Med; 2006 Mar; 47(3):534-42. PubMed ID: 16513624
[TBL] [Abstract][Full Text] [Related]
8. Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres.
Flamen P; Vanderlinden B; Delatte P; Ghanem G; Ameye L; Van Den Eynde M; Hendlisz A
Phys Med Biol; 2008 Nov; 53(22):6591-603. PubMed ID: 18978442
[TBL] [Abstract][Full Text] [Related]
9. 90Y PET-based dosimetry after selective internal radiotherapy treatments.
D'Arienzo M; Chiaramida P; Chiacchiararelli L; Coniglio A; Cianni R; Salvatori R; Ruzza A; Scopinaro F; Bagni O
Nucl Med Commun; 2012 Jun; 33(6):633-40. PubMed ID: 22407156
[TBL] [Abstract][Full Text] [Related]
10. Early dose response to yttrium-90 microsphere treatment of metastatic liver cancer by a patient-specific method using single photon emission computed tomography and positron emission tomography.
Campbell JM; Wong CO; Muzik O; Marples B; Joiner M; Burmeister J
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):313-20. PubMed ID: 19362251
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of high activity rhenium-188-microsphere in hepatic radioembolization.
Liepe K; Brogsitter C; Leonhard J; Wunderlich G; Hliscs R; Pinkert J; Folprecht G; Kotzerke J
Jpn J Clin Oncol; 2007 Dec; 37(12):942-50. PubMed ID: 18094017
[TBL] [Abstract][Full Text] [Related]
12. Targeting of liver tumour in rats by selective delivery of holmium-166 loaded microspheres: a biodistribution study.
Nijsen F; Rook D; Brandt C; Meijer R; Dullens H; Zonnenberg B; de Klerk J; van Rijk P; Hennink W; van het Schip F
Eur J Nucl Med; 2001 Jun; 28(6):743-9. PubMed ID: 11440035
[TBL] [Abstract][Full Text] [Related]
13. Selective Internal Radiation Therapy With Yttrium-90 Glass Microspheres: Biases and Uncertainties in Absorbed Dose Calculations Between Clinical Dosimetry Models.
Mikell JK; Mahvash A; Siman W; Baladandayuthapani V; Mourtada F; Kappadath SC
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):888-896. PubMed ID: 27623307
[TBL] [Abstract][Full Text] [Related]
14. An estimate of
Knešaurek K
Eur J Radiol; 2021 Jun; 139():109698. PubMed ID: 33848778
[TBL] [Abstract][Full Text] [Related]
15. Improving MRI-based dosimetry for holmium-166 transarterial radioembolization using a nonrigid image registration for voxelwise
Roosen J; van Wijk MWM; Westlund Gotby LEL; Arntz MJ; Janssen MJR; Lobeek D; van de Maat GH; Overduin CG; Nijsen JFW
Med Phys; 2023 Feb; 50(2):935-946. PubMed ID: 36202392
[TBL] [Abstract][Full Text] [Related]
16. Clinical effects of transcatheter hepatic arterial embolization with holmium-166 poly(L-lactic acid) microspheres in healthy pigs.
Vente MA; Nijsen JF; de Wit TC; Seppenwoolde JH; Krijger GC; Seevinck PR; Huisman A; Zonnenberg BA; van den Ingh TS; van het Schip AD
Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1259-71. PubMed ID: 18330569
[TBL] [Abstract][Full Text] [Related]
17. Clinical feasibility of fast 3-dimensional dosimetry of the liver for treatment planning of hepatocellular carcinoma with 90Y-microspheres.
Dieudonné A; Garin E; Laffont S; Rolland Y; Lebtahi R; Leguludec D; Gardin I
J Nucl Med; 2011 Dec; 52(12):1930-7. PubMed ID: 22068894
[TBL] [Abstract][Full Text] [Related]
18. Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up.
Andrews JC; Walker SC; Ackermann RJ; Cotton LA; Ensminger WD; Shapiro B
J Nucl Med; 1994 Oct; 35(10):1637-44. PubMed ID: 7931662
[TBL] [Abstract][Full Text] [Related]
19. Quantitative comparison of yttrium-90 (90Y)-microspheres and technetium-99m (99mTc)-macroaggregated albumin SPECT images for planning 90Y therapy of liver cancer.
Knesaurek K; Machac J; Muzinic M; DaCosta M; Zhang Z; Heiba S
Technol Cancer Res Treat; 2010 Jun; 9(3):253-62. PubMed ID: 20441235
[TBL] [Abstract][Full Text] [Related]
20. MRI-based biodistribution assessment of holmium-166 poly(L-lactic acid) microspheres after radioembolisation.
van de Maat GH; Seevinck PR; Elschot M; Smits ML; de Leeuw H; van Het Schip AD; Vente MA; Zonnenberg BA; de Jong HW; Lam MG; Viergever MA; van den Bosch MA; Nijsen JF; Bakker CJ
Eur Radiol; 2013 Mar; 23(3):827-35. PubMed ID: 23014797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
